Combination of mTOR and EGFR Kinase Inhibitors Blocks mTORC1 and mTORC2 Kinase Activity and Suppresses the Progression of Colorectal Carcinoma
- Type
- Retraction
- Notice date
- 8/26/2025 0:00
- Journal
- PLoS One
- Publisher
- PLoS
- Notice DOI
- 10.1371/journal.pone.0330746
- Original paper DOI
- 10.1371/journal.pone.0073175